Catherine B. Anders

763 total citations
16 papers, 604 citations indexed

About

Catherine B. Anders is a scholar working on Materials Chemistry, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Catherine B. Anders has authored 16 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Materials Chemistry, 4 papers in Biomedical Engineering and 3 papers in Biomaterials. Recurrent topics in Catherine B. Anders's work include Nanoparticles: synthesis and applications (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Graphene and Nanomaterials Applications (3 papers). Catherine B. Anders is often cited by papers focused on Nanoparticles: synthesis and applications (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Graphene and Nanomaterials Applications (3 papers). Catherine B. Anders collaborates with scholars based in United States and Germany. Catherine B. Anders's co-authors include Alex Punnoose, Denise Wingett, Jordan Chess, Josh Eixenberger, Mary Cloud B. Ammons, K. M. Reddy, Robert L. Tanguay, Leah C. Wehmas, Cliff Pereira and Jeffrey A. Greenwood and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Leukocyte Biology.

In The Last Decade

Catherine B. Anders

16 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine B. Anders United States 11 351 148 83 74 60 16 604
Charles Hanna United States 7 339 1.0× 161 1.1× 88 1.1× 87 1.2× 50 0.8× 11 544
Jorge Mejia Belgium 13 379 1.1× 165 1.1× 77 0.9× 70 0.9× 98 1.6× 26 570
Yu-Ri Kim South Korea 10 198 0.6× 71 0.5× 54 0.7× 114 1.5× 54 0.9× 31 552
Mir Yasir Arfat India 8 314 0.9× 184 1.2× 115 1.4× 120 1.6× 43 0.7× 12 643
Osman Arslan Türkiye 11 297 0.8× 176 1.2× 120 1.4× 47 0.6× 67 1.1× 19 527
James R. Swanson United States 4 450 1.3× 190 1.3× 142 1.7× 61 0.8× 131 2.2× 6 685
Céline Ohayon‐Courtès France 10 375 1.1× 134 0.9× 77 0.9× 81 1.1× 206 3.4× 17 645
Elizabeth I. Maurer United States 12 394 1.1× 204 1.4× 147 1.8× 74 1.0× 78 1.3× 15 566
Danhong Yan China 10 530 1.5× 239 1.6× 145 1.7× 118 1.6× 31 0.5× 14 772
José O. Flores–Flores Mexico 13 220 0.6× 129 0.9× 89 1.1× 58 0.8× 61 1.0× 29 518

Countries citing papers authored by Catherine B. Anders

Since Specialization
Citations

This map shows the geographic impact of Catherine B. Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine B. Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine B. Anders more than expected).

Fields of papers citing papers by Catherine B. Anders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine B. Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine B. Anders. The network helps show where Catherine B. Anders may publish in the future.

Co-authorship network of co-authors of Catherine B. Anders

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine B. Anders. A scholar is included among the top collaborators of Catherine B. Anders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine B. Anders. Catherine B. Anders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Eixenberger, Josh, et al.. (2024). On-demand release of encapsulated ZnO nanoparticles and chemotherapeutics for drug delivery applications. PubMed. 2(1). 82–93. 2 indexed citations
3.
Anders, Catherine B., et al.. (2019). Metabolic immunomodulation of macrophage functional plasticity in nonhealing wounds. Current Opinion in Infectious Diseases. 32(3). 204–209. 21 indexed citations
4.
Eixenberger, Josh, Catherine B. Anders, K. M. Reddy, et al.. (2019). Defect Engineering of ZnO Nanoparticles for Bioimaging Applications. ACS Applied Materials & Interfaces. 11(28). 24933–24944. 73 indexed citations
5.
Anders, Catherine B., Josh Eixenberger, Katherine D. Rainey, et al.. (2018). ZnO nanoparticle preparation route influences surface reactivity, dissolution and cytotoxicity. Environmental Science Nano. 5(2). 572–588. 24 indexed citations
6.
Eixenberger, Josh, Catherine B. Anders, Raquel J. Brown, et al.. (2017). Rapid Dissolution of ZnO Nanoparticles Induced by Biological Buffers Significantly Impacts Cytotoxicity. Chemical Research in Toxicology. 30(8). 1641–1651. 50 indexed citations
7.
Wingett, Denise, Panagiota Louka, Catherine B. Anders, Jianhui Zhang, & Alex Punnoose. (2016). A role of ZnO nanoparticle electrostatic properties in cancer cell cytotoxicity. SHILAP Revista de lepidopterología. Volume 9. 29–45. 35 indexed citations
8.
Anders, Catherine B., Jordan Chess, Denise Wingett, & Alex Punnoose. (2015). Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models. Nanoscale Research Letters. 10(1). 448–448. 64 indexed citations
9.
Wehmas, Leah C., Catherine B. Anders, Jordan Chess, et al.. (2015). Comparative metal oxide nanoparticle toxicity using embryonic zebrafish. Toxicology Reports. 2. 702–715. 99 indexed citations
10.
Punnoose, Alex, et al.. (2014). Cytotoxicity of ZnO Nanoparticles Can Be Tailored by Modifying Their Surface Structure: A Green Chemistry Approach for Safer Nanomaterials. ACS Sustainable Chemistry & Engineering. 2(7). 1666–1673. 130 indexed citations
11.
Anders, Catherine B., et al.. (2012). Tangential Flow Ultrafiltration: A "Green" Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles. Journal of Visualized Experiments. 16 indexed citations
12.
Anders, Catherine B.. (2012). A SERS and SEM-EDX Study of the Antiviral Mechanism of Creighton Silver Nanoparticles against Vaccinia Virus. Journal of Bioresource Management. 1 indexed citations
13.
Anders, Catherine B., et al.. (1999). Investigation into the mechanism of bacterial adhesion to hydrogel-coated surfaces. Journal of Materials Science Materials in Medicine. 10(10-11). 649–652. 9 indexed citations
14.
Anders, Catherine B., et al.. (1999). SURFACE MODIFICATION WITH HYDROGELS VIA MACROINITIATORS FOR ENHANCED FRICTION PROPERTIES OF BIOMATERIALS. Journal of Macromolecular Science Part A. 36(7-8). 1017–1029. 9 indexed citations
15.
Vieler, E., Tobias Schlapp, Catherine B. Anders, & W. Herbst. (1995). Genomic relationship of porcine hemagglutinating encephalomyelitis virus to bovine coronavirus and human coronavirus OC43 as studied by the use of bovine coronavirus S gene-specific probes. Archives of Virology. 140(7). 1215–1223. 12 indexed citations
16.
Anders, Catherine B., et al.. (1958). H-Ionenkonzentration und CO2-Gehalt der Galle bei Cholelithiasis. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 309(Jahresband). 60–76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026